Monte Rosa Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Detailed price information for Monte Rosa Therapeutics Inc (GLUE-Q) from The Globe and Mail including charting and trades.
Goldman Sachs raises AbbVie stock price target to $208
Goldman Sachs updated its financial model for AbbVie (NYSE:ABBV), leading to an increase in the price target for the ...
Piper Sandler raises AbbVie stock target to $227, keeps Overweight rating
Piper Sandler adjusted its financial outlook for pharmaceutical giant AbbVie (NYSE:ABBV), which currently commands a market capitalization of $301 billion, citing upcoming charges and anticipated ...
AbbVie price target raised to $227 from $220 at Piper Sandler
Piper Sandler analyst Christopher Raymond raised the firm’s price target on AbbVie (ABBV) to $227 from $220 and keeps an Overweight rating on ...
Piper Sandler Sticks to Its Buy Rating for AbbVie (ABBV)
In a report released today, Christopher Raymond from Piper Sandler maintained a Buy rating on AbbVie (ABBV – Research Report), with a price ...
Wall Street Journal6h
Monte Rosa Therapeutics Inc.
1 Day GLUE 0.36% DJIA -0.32% Russell 2K -0.30% Health Care/Life Sciences -0.52% ...